Inhaled corticosteroid treatment and pneumonia in patients with chronic obstructive pulmonary disease – nationwide development from 1998 to 2018
Background A decreasing use of inhaled corticosteroids (ICS) in patients with a hospital-registered diagnosis of chronic obstructive pulmonary disease (COPD) has recently been documented in Denmark. ICS treatment is not recommended in patients with high pneumonia risk, and we aimed to assess the dev...
Saved in:
| Main Authors: | Allan Klitgaard, Rikke Ibsen, Jesper Lykkegaard, Ole Hilberg, Anders Løkke |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | European Clinical Respiratory Journal |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20018525.2024.2359768 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Urban–rural differences in pneumonia risk in patients with chronic obstructive pulmonary disease: a nationwide register-based study
by: Allan Klitgaard, et al.
Published: (2025-12-01) -
Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study
by: Sung Hye Kong, et al.
Published: (2025-02-01) -
Oral health status of asthmatic children using inhaled corticosteroids
by: Münevver Doğan, et al.
Published: (2021-02-01) -
Efficacy of Inhaled Corticosteroids in Patients with Bronchiectasis without Airway Hyperresponsiveness: A Pilot Study
by: Safia Ahmed, et al.
Published: (2024-11-01) -
Treatment with oral or inhaled bronchodilator without inhaled corticosteroids in bronchial asthma: A dangerous weapon!
by: Shital Patil, et al.
Published: (2023-05-01)